Top Markets
#1 Cortex Cortex +32.78%
#2 龙虾 (Lobster) 龙虾 (Lobster) +28.15%
#3 DexNet DexNet +23.20%
#4 Akedo Akedo +23.10%
#5 wojak wojak +17.64%
#6 Pons Pons +16.45%
#7 OpenEden OpenEden +12.59%
#8 Official Trump Official Trump +10.20%
#9 EXOD EXOD +9.04%
#10 Peapods Finance Peapods Finance +8.29%
Coin of the day
Cortex Cortex
Setări
Limbă
ROMâNă
Monedă
USD
Temă
HBM Holdings Limited HBM Holdings Limited

HBM Holdings Limited

2142
Rang în acțiuni #7239
HBM Holdings Limited is a clinical-stage biopharmaceutical enterprise focused... HBM Holdings Limited is a clinical-stage biopharmaceutical enterprise focused on identifying and developing unique antibody-based treatments for a variety of immunological conditions and cancers. The company's pipeline includes several promising assets. In immunology, Batoclimab (HBM9161) is a human monoclonal antibody specifically designed to bind and inhibit the neonatal fragment crystallizable receptor, while Tanfanercept (HBM9036) is under development to address moderate to severe dry eye disease. For oncology, HBM Holdings is advancing various therapies, such as HBM7008, a bispecific antibody targeting tumor-associated antigens, and HBM4003, a human anti-CTLA-4 antibody. Additional cancer candidates in their portfolio include HBM9302 for breast and gastric cancers, HBM7020 for multiple myeloma, and a suite of treatments—HBM1007, HBM1029, HBM7015, HBM7008, and HBM1022—geared towards solid tumors. Furthermore, HBM9022 is being developed to treat SARS-COV-2. Operating globally, HBM Holdings has a presence in Mainland China, the United States, Europe, and other international markets. The company also fosters strategic partnerships for antibody-drug conjugate (ADC) projects with LegoChem Biosciences Inc. and Duality Biotherapeutics, Inc. HBM Holdings Limited was founded in 2016 and is based in Shanghai, People's Republic of China.
Preț acțiune
$1.99
Capitalizare de piață
$1.67B
Schimbare (1 zi)
-4.66%
Schimbare (1 an)
22.01%
Țară
CN
Tranzacționează HBM Holdings Limited (2142)

Categorie

Healthcare
Istoric al prețului acțiunii pentru HBM Holdings Limited (2142)
Cel mai mare preț de închidere: $1.98 pe 2026-08-01

Cel mai mic preț de închidere: $1.35 pe 2020-12-01
Istoric al prețului acțiunii pentru HBM Holdings Limited din 2020 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -0.88%
2025 894.28%
2024 -16.69%
2023 -21.19%
2022 -75.51%
2021 -21.32%
2020 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.36 39.87%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 50.29%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.14 -12.77%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.81 475.44%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.74%
CH